A cell-to-cell HIV transfer assay identifies humoral responses with broad neutralization activity-Reference-Cited by-同舟云学术

A cell-to-cell HIV transfer assay identifies humoral responses with broad neutralization activity

Published:2011-07 Issue:32 Volume:29 Page:5250-5259
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Sánchez-Palomino Sonsoles,Massanella Marta,Carrillo Jorge,García Ana,García Felipe,González Nuria,Merino Alberto,Alcamí José,Bofill Margarita,Yuste Eloísa,Gatell Josep M.,Clotet Bonaventura,Blanco Julià

Funder

ISCIII

Health Department of the Catalan Government (Generalitat de Catalunya)

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference37 articles.

1. Inhibition of virus attachment to CD4+target cells is a major mechanism of T cell line-adapted HIV-1 neutralization;Ugolini;J Exp Med,1997

2. Neutralizing antibodies against the V3 loop of human immunodeficiency virus type 1 gp120 block the CD4-dependent and -independent binding of virus to cells;Valenzuela;J Virol,1997

3. Sequential CD4-coreceptor interactions in human immunodeficiency virus type 1 Env function: soluble CD4 activates Env for coreceptor-dependent fusion and reveals blocking activities of antibodies against cryptic conserved epitopes on gp120;Salzwedel;J Virol,2000

4. Seronegative HIV-1 infection: a review of the literature;Spivak;AIDS,2010

5. Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target;Walker;Science,2009

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of mRNA1273 SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Single center experience;Medicina Clínica (English Edition);2024-04

2. Efficacy and safety of mRNA1273 SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Single center experience;Medicina Clínica;2023-11

3. An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responses;npj Vaccines;2023-04-06

4. Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralization;iScience;2023-04

5. Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2;iScience;2023-03